Literature DB >> 21268004

TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.

Yuh-Ching Twu1, Michael R Gold, Hung-Sia Teh.   

Abstract

Members of the TNF and TNF receptor (TNFR) superfamily play important roles in the maintenance of homeostasis of the immune system. Furthermore, several members of the TNFR family participate in T-cell activation and sustaining T-cell responses. We have shown that TNFR2 regulates T-cell activation by lowering the activation threshold and providing costimulatory signaling. Furthermore, activated TNFR2(-/-) CD8(+) T cells are highly resistant to activation-induced cell death (AICD). Here, we showed that using anti-TNFR2 antibodies to block TNFR2 on activated WT CD8(+) T cells rendered them resistant to AICD. This resistance of activated TNFR2(-/-) CD8(+) T cells to AICD correlated with the accumulation of TNF receptor-associated factor 2 (TRAF2). Overexpression of TRAF2 by retroviral transfection and knockdown of TRAF2 by small interfering RNA also support this conclusion. Furthermore, neutralizing TNF-α reduced TRAF2 accumulation in activated TNFR2(-/-) CD8(+) T cells and increased their susceptibility to AICD. AICD-resistant TNFR2(-/-) CD8(+) T cells expressed elevated levels of phosphorylated IκBα and higher DNA-binding activity of the p65 NK-κB subunit and neutralization of TNF-α blocked this increase. Therefore, in activated TNFR2(-/-) CD8(+) T cells, TNFR1 functions as a survival receptor by utilizing high intracellular levels of TRAF2 to promote IκBα phosphorylation and NF-κB activation.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21268004     DOI: 10.1002/eji.201040639

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

Review 1.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

2.  Combined use of etanercept and MTX restores CD4⁺/CD8⁺ ratio and Tregs in spleen and thymus in collagen-induced arthritis.

Authors:  B Huang; Q T Wang; S S Song; Y J Wu; Y K Ma; L L Zhang; J Y Chen; H X Wu; L Jiang; W Wei
Journal:  Inflamm Res       Date:  2012-07-17       Impact factor: 4.575

3.  Indolent T-cell lymphoproliferative disease of the gastrointestinal tract after treatment with adalimumab in resistant Crohn's colitis.

Authors:  Natalia Edison; Hila Belhanes-Peled; Yuval Eitan; Yifat Guthmann; Yelena Yeremenko; Mark Raffeld; Irit Elmalah; Philippe Trougouboff
Journal:  Hum Pathol       Date:  2016-07-08       Impact factor: 3.466

4.  Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.

Authors:  Shivesh Punit; Philip E Dubé; Cambrian Y Liu; Nandini Girish; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2015-06-11       Impact factor: 22.682

Review 5.  TNF activity and T cells.

Authors:  Amit K Mehta; Donald T Gracias; Michael Croft
Journal:  Cytokine       Date:  2016-08-13       Impact factor: 3.861

6.  A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.

Authors:  Mengmeng Jiang; Jia Liu; Debra Tross; Ping Li; Fengyang Chen; Md Masud Alam; Denise L Faustman; Joost J Oppenheim; Xin Chen
Journal:  Int Immunopharmacol       Date:  2021-11-15       Impact factor: 4.932

7.  Redistribution of TNF Receptor 1 and 2 Expression on Immune Cells in Patients with Bronchial Asthma.

Authors:  Alina Alshevskaya; Julia Zhukova; Fedor Kireev; Julia Lopatnikova; Irina Evsegneeva; Daria Demina; Vera Nepomniashchikch; Victor Gladkikh; Alexander Karaulov; Sergey Sennikov
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

8.  Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection.

Authors:  Xiaohua Dong; Yuanjun Liu; Xiaotong Chang; Lei Lei; Guangming Zhong
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

Review 9.  Insights into the biology and therapeutic implications of TNF and regulatory T cells.

Authors:  Benoit L Salomon
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 20.543

10.  Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells.

Authors:  Alessio Papi; Gianluca Storci; Tiziana Guarnieri; Sabrina De Carolis; Sara Bertoni; Nicola Avenia; Alessandro Sanguinetti; Angelo Sidoni; Donatella Santini; Claudio Ceccarelli; Mario Taffurelli; Marina Orlandi; Massimiliano Bonafé
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.